TNF and colitis: Oral administration of OMVs secreted by EcN has also been described to exert intestinal anti-inflammatory effects in the DSS experimental murine colitis model, reducing the expression of pro-inflammatory cytokines such as IL-1β, TNFα, and IL-17 in comparison with control mice, similarly to live EcN.